Bill A.

Family Wealth and Asset Manager

📍 United States🔄 Updated September 2026💼 6 investments📅 25 years investing🗓 Last invested Jan 2020
Angel investor🌍 United States
6
Total investments
1
Early stage
1
Mid stage
1
Late stage
25y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2020
TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations.
Seed Investor
Aug 2017
Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage-to-orbit spaceplane, delivering people and cargo to low Earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations.
Investor
Mar 2016
Curza is a small molecule therapeutics development company. Curza has developed a new class of antibiotics that are active and selective against Gram-negative pathogens.
Experience · 8 entries
All (8)
Investments (6)
2020
Investor
Jan 2020
TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations.
2018
Principal
Jan 2018
Wonder Worldwide is an entertainment production company focussing on feature film and television development, financing, and production.
2017
Seed Investor
Aug 2017
Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage-to-orbit spaceplane, delivering people and cargo to low Earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations.
2016
Investor
Mar 2016
Curza is a small molecule therapeutics development company. Curza has developed a new class of antibiotics that are active and selective against Gram-negative pathogens.
2012
Arrogene, Inc.
Investor
Jan 2012
mid stage
Show all 8 entries ↓
Investment activity
2001–2020 · 6 investments
200112007120121201612017120201
Recent (last 2 years)Earlier